Literature DB >> 16075378

Nicotinic agonists, antagonists, and modulators from natural sources.

John W Daly1.   

Abstract

1. Acetylcholine receptors were initially defined as nicotinic or muscarinic, based on selective activation by two natural products, nicotine and muscarine. Several further nicotinic agonists have been discovered from natural sources, including cytisine, anatoxin, ferruginine, anabaseine, epibatidine, and epiquinamide. These have provided lead structures for the design of a wide range of synthetic agents. 2. Natural sources have also provided competitive nicotinic antagonists, such as the Erythrina alkaloids, the tubocurarines, and methyllycaconitine. Noncompetitive antagonists, such as the histrionicotoxins, various izidines, decahydroquinolines, spiropyrrolizidine oximes, pseudophrynamines, ibogaine, strychnine, cocaine, and sparteine have come from natural sources. Finally, galanthamine, codeine, and ivermectin represent positive modulators of nicotinic function, derived from natural sources. 3. Clearly, research on acetylcholine receptors and functions has been dependent on key natural products and the synthetic agents that they inspired.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075378     DOI: 10.1007/s10571-005-3968-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  198 in total

1.  Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors.

Authors:  J E Spang; S Bertrand; G Westera; J T Patt; P A Schubiger; D Bertrand
Journal:  Chem Biol       Date:  2000-07

2.  RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

Authors:  M Bencherif; M E Lovette; K W Fowler; S Arrington; L Reeves; W S Caldwell; P M Lippiello
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

3.  Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

Authors:  C A Briggs; D J Anderson; J D Brioni; J J Buccafusco; M J Buckley; J E Campbell; M W Decker; D Donnelly-Roberts; R L Elliott; M Gopalakrishnan; M W Holladay; Y H Hui; W J Jackson; D J Kim; K C Marsh; A O'Neill; M A Prendergast; K B Ryther; J P Sullivan; S P Arneric
Journal:  Pharmacol Biochem Behav       Date:  1997 May-Jun       Impact factor: 3.533

4.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

Authors:  A R Davies; D J Hardick; I S Blagbrough; B V Potter; A J Wolstenholme; S Wonnacott
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

6.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.

Authors:  F I Carroll; J R Lee; H A Navarro; L E Brieaddy; P Abraham; M I Damaj; B R Martin
Journal:  J Med Chem       Date:  2001-11-22       Impact factor: 7.446

7.  Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.

Authors:  C Souccar; W A Varanda; R S Aronstam; J W Daly; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

8.  Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.

Authors:  Christopher G V Sharples; Gunter Karig; Graham L Simpson; James A Spencer; Emma Wright; Neil S Millar; Susan Wonnacott; Timothy Gallagher
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

9.  Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.

Authors:  X Zhang; Z H Gong; K J Fasth; B Långström; A Nordberg
Journal:  Neurochem Int       Date:  1998 May-Jun       Impact factor: 3.921

10.  Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.

Authors:  M W Decker; D J Anderson; J D Brioni; D L Donnelly-Roberts; C H Kang; A B O'Neill; M Piattoni-Kaplan; S Swanson; J P Sullivan
Journal:  Eur J Pharmacol       Date:  1995-06-23       Impact factor: 4.432

View more
  44 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Organometallic enantiomeric scaffolding: a strategy for the enantiocontrolled construction of regio- and stereodivergent trisubstituted piperidines from a common precursor.

Authors:  Heilam Wong; Ethel C Garnier-Amblard; Lanny S Liebeskind
Journal:  J Am Chem Soc       Date:  2011-04-22       Impact factor: 15.419

3.  Enhanced meta-analysis of acetylcholine binding protein structures reveals conformational signatures of agonism in nicotinic receptors.

Authors:  Spencer T Stober; Cameron F Abrams
Journal:  Protein Sci       Date:  2012-03       Impact factor: 6.725

4.  The natural history of consciousness, and the question of whether plants are conscious, in relation to the Hameroff-Penrose quantum-physical 'Orch OR' theory of universal consciousness.

Authors:  Peter W Barlow
Journal:  Commun Integr Biol       Date:  2015-07-09

5.  Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.

Authors:  Richard W Fitch; Thomas F Spande; H Martin Garraffo; Herman J C Yeh; John W Daly
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

6.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

Authors:  Sheela K Chellappan; Yingxian Xiao; Werner Tueckmantel; Kenneth J Kellar; Alan P Kozikowski
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

7.  Practical total syntheses of epiquinamide enantiomers.

Authors:  Takashi L Suyama; William H Gerwick
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

8.  Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.

Authors:  Alexandre Maciuk; Ruin Moaddel; Jun Haginaka; Irving W Wainer
Journal:  J Pharm Biomed Anal       Date:  2007-11-26       Impact factor: 3.935

Review 9.  Use of venom peptides to probe ion channel structure and function.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

10.  Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons.

Authors:  Taixiang Saur; Bruce M Cohen; Qi Ma; Suzann M Babb; Edgar A Buttner; Wei-Dong Yao
Journal:  J Neurogenet       Date:  2016-09-14       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.